Publication | Closed Access

Serum markers of cardiovascular risk in patients with acromegaly before and after six months of treatment with octreotide LAR

ThrombosisOctreotide LarCardiovascular DiseaseCardiovascular RiskEndocrinologyMedicineAtherosclerosisSerum Markers